Bill to let pharmacists prescribe and administer more vaccines advances to work session after broad support and insurer concerns
Loading...
Summary
Representative Sally Clucci told the committee LD 2,071 (sponsored as LD 2071 in the transcript) would codify an access framework that lets trained pharmacists prescribe, dispense and administer FDA-licensed vaccines, mandates insurer coverage without cost-sharing, and removes a duplicate 72-hour PCP notification requirement; health-care providers and pharmacy groups backed the measure while insurers urged ACIP retention and careful effective dates.
Representative Sally Clucci presented LD 2,071 to the Health Coverage, Insurance and Financial Services Committee and described an amendment that would allow pharmacists who meet training and licensure standards to prescribe, dispense and administer FDA-licensed vaccines under clearly defined statutory authority.
Clucci said the amendment removes a 72-hour primary-care notification requirement because vaccination events are already reported to the states immunization information system (IMPACT), and it requires insurer coverage without cost-sharing for vaccines recommended by nationally recognized evidence-based medical organizations. She emphasized that the bill "does not in any way mandate vaccination" and does not create a new statewide vaccine program.
Key operational points in the amendment would allow pharmacists to prescribe and administer flu and COVID-19 vaccines to people 6 months and older and permit pharmacists to prescribe and administer other FDA-licensed vaccines for adults (and with limits for younger children consistent with the amendment). The amendment also clarifies that properly trained pharmacy interns may administer vaccines under direct pharmacist supervision.
Pharmacy groups, health systems and pediatricians largely supported the change. Amy Dowling Downing of the Maine Pharmacy Association said the bills align statute with clinical practice and protect pharmacists working within recognized standards; Paul Monroe Jr. of Penobscot Community Health Care highlighted data showing the share of adult vaccines given in pharmacies rose substantially between 2018 and 2022 and said the legislation would reduce delays caused by prescriber requirements. Dennis Wood of Northern Light Health and Dr. Joseph Anderson for the Maine chapter of the American Academy of Pediatrics also offered supportive testimony.
Insurers and health-plan representatives urged caution. Dan Demeritt of the Maine Association of Health Plans asked the committee to retain the ACIP reference to preserve consistency with the Affordable Care Acts first-dollar coverage requirement, and Anthems Christine Ossenfort recommended an effective date tied to plan certification cycles (examples cited during testimony included 01/01/2027).
Committee members asked follow-up questions about how providers access the IMPACT registry and who is authorized to view records; staff said they would provide details at the work session. The public hearing closed with the committee indicating it will take the bills up again in a work session for further drafting and to address technical questions.
